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A lirniting dilution assay was developed to quantitate uru-
shiol (the antigen of poison ivy; Toxicodetldroll radicalls) spe-
ci fi c T cells from peripheral blood of a patient with a history 
of rhus (poison ivy) dermatitis. It was found that maximal 
sensitivity with minimal nonspecific proliferation could be 
produced with the use of 5 U / ml of recombinant IL2 added 
to the assay on day 6. This donor was found to have a fre-
9"ency of urushiol specific peripheral blood T cel ls of 
(1/2935). Five interleukin 2 (IL2) dependent urushiol spe-
cific T-cell clones were generated from the peripheral blood 
of this patient. These T-cell clones had a CD8+ (T8+) phe-
notype and proliferated speciJically to both extracts of Toxi-
cod. lldroll radieallS (poison ivy) leaves and pure urushiol. Pen-
wdccylcatcchol was an inferior antigen. only stimulating 
proliferation of one clone. The ability of all clones to prolif-
erate to pure urushiol. despite theif having been induced with 
RhUS dermaticis caused by ToxilOJewiro" radicalJs (poi-son ivy) has the characteristics of a delayed type hyper-sensitivity (DTH) and is known co be the result of sensitization to the hapten urushio l [t ,21. Animal models have shown that cutaneous delayed hypersen-
sitivity may be mediated by either CD4+ (L3T4+) clones 13J or 
CD8+ (Lyt2+) clones 14J. although the majority ofDTH inducing 
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Abbreviations: 
ConA: concanavalin A 
DMSO: dimethysulfoxide 
DTH: delayed type hypersensitivi ty 
E+: sheep erythrocyte receptor positive cells 
E-: sheep eryth rocyte receptor negative cells 
FCS: fetal calf serum 
IFN: mterferon 
Il2: intcrleukin 2 
l OA: limiting dilution analysis 
lDCC: leCtIn depcndrllt cellular cytotoxicity 
NK : natural killer 
PBM: penpheral blood mononuclear cdl (lymphocytes & monocytes) 
PDe: pentadecylcatechol 
PWM: pokeweed mitogen 
rll2: recomblllant Il2 
leaf ex tract, suggests that urushiol. or closely related cate-
chols, represent the only allerge nic constituents of Toxico-
dendron radicans. Lyrnphokine production in response to ant i-
gen varied between (0.6- 5.0) units/ 1ll1 ofinterleukin 2 (IL2) 
and (1.0- 120) units/ ml of gamma interferon. Although 
none of the clones showed significant cyro[Qxicity against 
NK targets, three of five lines showed considerable cytotox-
icity against concanavaJin A treated (lectin approximated) 
targets. However, cytotoxicity for rhus conjugated autolo-
gous targets was not detected. It was found that severaJ of 
these CD8+ clones could suppress IgG production in the 
presence of rhus antigen. The isolation of these T-cells from 
peripheral blood several months after rhus dermatitis sug-
gests that these clones may have a role in down regulating 
delayed hypersensi tivity to urushiol. } III vest Dermato! 
92:46 - 52, 1989 
clones arc reported to be CD4+. Allergic COJl[act dermatitis in 
humans has nor been studied as well as on an in vitro cellular level. 
Nickel sulfate specific CD4+ cells have been cloned [rom the pe-
ripheral blood [5] and skin lesions 16] of patients with nickel sensi-
tivity. No CD8+ nickel sulfate reactive clones were generated and 
the clones produced significant levels of both J L2 and gamma incer-
feron upon stimu1ation with nickel sulfate. Interestingly, several 
clones only recognized nickel su lfate when presented by epidermal 
antigen-presenting cells [6]. Similar cobalt ch loride specific C04+ 
T-cell lines have been derived from the peripheral blood of patients 
sensi tive to cobal t [7J. Human T cells have also been cloned from 
skin lesions of lepromatous leprosy IS]. The goal of this srudy was, 
first, to develop techniques to quantitate the number of urushiol 
specific cells in blood and. second. to clone and characterize uru-
shiol speci fic T ce ll s. This quantitative approach should both yield a 
greater understanding of delayed hypersensitivity reactions and de-
velop a methodology useful for investigating other cell mediated 
condi tions which are less well understood. An additional goal was to 
determine if urushiol or related catcchols represent the sole anti-
genic constituent of Toxirodctldro" radic(JtIS. 
The urushiol antigenic system has been well worked out in both 
humans 11 J and animals [21 by in vivo 121 and in vitro [91 techniques. 
Urushiol. the antigen responsible for rhus dermatitis, is a catechol 
ring with a C 15 ta il containing two unsaturated bonds. Pentadecy l-
catechol (POC), a similar molecule without the unsaturated bonds. 
is an inferior antigen both in vivo [2] and in vitro [9]. The lipophilic 
rail is believed ro be necessary for insertion into the lipid bilayer, 
although a second, covalent interaction of the ring structure has also 
been hypothesized 12,10]. Studying the proliferative response of 
human peripheral blood mononuclear ce lls (PUM) to urushiol con-
jugated erythrocytes, Vera Byers et al have found rhat in vi tro pro-
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liferative responses are weak and rarely present more than 2 months 
post clinical dermatitis [9). 
A limiting dilurion assay was developed, capable of quanritating 
urushiol speci fic precursors in peripheral blood. In addition. five 
urushiol speci fic IL2-dcpcndcnt T-cell clones were generated from 
the peripheral blood of a urushiol sensitive donor using cmde leaf 
extracrs as a source of antigen. These clones were predominantly 
CDS+ and proliferated specifically to both extracts of ToxiroJl.'tlJron 
raJicatls (poison ivy) leaves and pure urushiol. Low levc:ls of IL2 and 
varying levels of gamma interferon were produced after antigen 
stimulation. CytOtoxicity againsc NK rargets was minimaL How-
ever, several clones exhibited considerable cytotoxicity for lectin 
approximated targets . The abi lity of these clones to proliferate in 
response to both urushiol and leaf extract suggests that urushiol, or 
related catcchols. are fully responsible for the antigenicity of Toxico-
dwJro" rodicoflS. 
Several of these CD8+ urushiol speci fic clones were found to 
suppress pokeweed mitogen induced IgG production when rrig-
gered by rhus. The isolation of these rhus triggered suppressor cells 
from peripheral blood of a patient several months after rhus derma-
titis suggests that such clones may have a role in down regulating 
the response to contact allergens. 
MATERIALS AND METHODS 
Preparation ofPeripberal Blood Mononuclear CeUs (PBM) 
Hcpariniud peripheral venous blood was separated into PDM by 
centrifugation on Ficoll-Hypaque (Pharmacia. Piscataway. NJ) gra-
dients, followed by washing. Sheep red blood cdl receptor positive 
(E+) T cells and receptor negative (E-) non-T cells were isolated by 
roserring followed by centrifugation over a Ficoll-Hypaque gra-
dient and lysis of sheep erythrocytes by ammonium chloride as 
described [I 1]. 
Production of 1L2 Containing Conditioned Medium Crude 
IL2 preparations were generated by treatment ofPBM isolated from 
butTy coat from platelet donations with 4 Jlg/ml phytohemagglu-
tinin (Burroughs Wellcome. Research Triangle Park, NC) and (5 
nanograms/m]) O-tctradccanoylphorbol-13-aceute (Sigma. St. 
Louis, MO) for 4 h" 37"C (I X 10' cells/ml). The cells were then 
washed four times and resuspended (I X 10' cells/ml) in RPMI 
1640 (Gibco, Grand Island, NY) containing 1% FCS (HyClone 
L.1bs, Logan, UT), 5 Jlg/mJ gentamycin (Schering, Kenilworth, 
NJ), and 4 111M gluramine (Microbiological Associates. W alkers-
ville, MD). The cells were cul tured 72 h in 250 em' flasks (Corn-
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ing. Corning. NY), and the conditioned medium was harvested by 
centrifugation. Preparations were tested for their ability to maxi-
mally support the growth of IL2 dependent human cell lines at a 
10% final concentration of conditioned medium. 
Antigens Rhus exrract was made by extracting 18 gm ToxiroJe,,-
drOll raJicotis (poison ivy) leaves with 151111 of dimethysulfoxide 
(DMSO) for 15 h at 4°C . The material was then filtered through a 
0.20 Jim filter. aliquotted. and stored at -70°C. Potency was deter-
mined by the ability to induce proliferation of PBM from rhus 
sensitive donors. It was found that a dilution of 1 : Soo to 1 : 1200 
gave maximal proliferation. PBM from donors nOt sensitive to rhus. 
or dOllors whose last episode of rhus dermatitis was over 12 months 
previous did not respond. 
Purified urushiol from Toxi(oJe"drMI rodicom and synthetic pen-
tadecylcatachol (POe) were the generous gifts of Dr. H. Baer of the 
Dureau of Biologics. Food and Drug Administration (Bethesda. 
MD). Analysis of the purified urushiol by gas chromatography 
showed no saturated side chains and a minimum of 95% caeechol 
(Dr. H. Baer. personal communication). The material was 85. 1 % 
CIS rriene, 10.2% combination mono and diene, and 4.7% C I7 
triene. 
Tetanus toxoid was obtained from the Massachusetts State Bio-
logical Laboratory Uamaican Plain, MA) and was used at a I : 200 
final dilution. 
Limiting Dilution Frequency Analysis of Antigen Specific T 
Cells Peripheral blood T cells. derived from E-rosetting. were 
added to 96-well V -bottom plates (Linbro. Flow Laboratories, 
Mclean, VA) along with 5 X 10' irradiated (4000R) PBM, which 
act both as antigen-presenting cells and feeder cells. The numbers of 
T cells added per well were 3 X 10', 1 X 10', or 3 X 10'. Sixty 
wells were used per group (180 wells per determination). Condi-
tions used included no exogenous antigen (A) or rhus extract 
(I: 800) (B). Recombinant IL2 (r1L2; Boehringer MalUlheim, Indi-
anapolis, IN) was added as indicated. Following this initial addition 
of rIL2, rhe culture media was changed every 4 d with the addition 
RPMI 1640 containing 10% conditioned medium and 10% FCS 
(see above). Wells were scored for visible growth after 21 d. In 
preliminary experiments no additional positive wells were detected 
after 21 d. 
Statist ical ana lysis was performed by the Chi-square minimiza-
tion method of Taswell [12J using a computer program provided by 
Dr. D. Scon Schmid {13] from rhe Centers for Disease Control 
(Atlanta. GA). Graphic representation of the results (Fig I) was 
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Figure 1. Limiting di lution analysis was performed using peripher:l.l blood T cells:l.5 described. Responder cells per well were plotted :l.gainSl Log (% 
nonresponding wel ls) and a line derived by line:l.r regression analysis. Error bars re fl ect 95% confidence intervals. A: Recombinant Il2 (r1L2) 5 U/m! was 
added:l.t iniri:l.oon of cultures. B: rIL2 (5 U/ml) was added on day 6. C: rll2 (20 U/ml) was added 011 day 6. 
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obtained by conversion of percenc nonresponding wells to log (% 
nonresponding) and plotting against number of cells per well as the 
x axis 114]. Er,or bars (95% confidence interval) were determined 
from the binomial distribution for N = 60. Each curve represents 
180 wells wi,h 60 wells per data poin'. 
Generation of Urushiol Specific T-cell Clones PBM from a 
urushiol sensitive donor, 11 months post rhus dermatitis , were sen-
sitized in vitro {in vitro secondary response} against rhus extract 
(I: 800) for 7 d in 10% human AB sera (Pd Freeze. RogetS. AR) 
supplemented RPMI 1640 medium containing 4 111M glutamine. 
25 mM HEPES. gencamycin. and 0.5% sodium bicarbonate. The 
line was then carried in IL2 media consisting of RPM I 1640 con-
taining 10% FCS (HyClone Labs. Logan. UT). 10% IL2 con'aining 
conditioned medium (approximately 3 U/ml final concentration), 
4 mM glutamine and 5 J.lm/ml gentamycin. Following 2 weeks of 
culture the line was subcloned by limiting dilution in V-bottomed 
wells (96 well trays. Linbro. Flow Laboratories. Mclean. VA) a' one 
cell per well along with rhus extract (1: 800) and autologous anti-
gen-presen,ing cdls (PBM irradiated sOOOR. I X 10' / well) in 10% 
IL2 containing conditioned media. IL2 medium was changed every 
3 d. After 3 weeks of growth, positive wells were expanded to 
U-bottom wells with the use of rhus extract and autologous irra-
diated PBM. Growth of the T -cdl clones was maintained by feed-
ing with IL2 media every 3 days and addition of antigen with 
autologous irradiated PBM as needed, generally every 2 weeks. 
Clones derived in this manner have been cultured for up to 6 
months withom loss of antigen specificity. The term "clone" is used 
with the stipulation that clonality was not proven. 
Phenotype Analysis T-cell clones were stained by indirect im-
munofluorescence with goat anti-mouse FITC (Tago, Burlingame, 
CA) and analyzed using an Epics C cyto£luorograph (Coulter Elec-
tronics. Hialeah. FL). The monoclonal antibodies used includeantj-
T3 (CD3). an,i-T4 (CD4). an,i-TS (CDS). and an,i-NKHI 
(Coulter Immunology. Hialeah. FL). 
Proliferation of IL2 Dependent Cells Responder cells were 
washed three times to remove IL2 and resuspended in sUJ?plemented 
RPMI 1640 media containing 10% human AB serum (Pel Freeze, 
Rogers. AR). counted. and adjusted '0 I X 10'cdls/ml in ,he above 
media. Autologous PBM to be used as antigen-presencing cells were 
irradiated 5000R, (Cesium Source) washed. and resuspended at 1 X 
106 cells/ml in the above human serum media. Responder cells 
(I X 10S(well) were then added to round bottom microtiter wells 
(96-wel tray. Nunc/ lntermed. Thousand Oaks. CAl. 100 III per 
well, four wells per group. The experimental variables were then 
added in a volume of I 00 III per wdl. These included media alone. 5 
U / mIIL2. and (2 X 10'/wdl) au,ologous sOOOR irradiated PBM 
in the presence or absence of various antigens. The cells were cul-
tured 24 hours at 37 °C in 7.5% COl prior to addition oflH-thymi-
dine for a final 18 h incubation. Cells were then harvested and 
lH-thymidine uptake determined by scintillation counting. 
Rhus extract (in OMSO) was used at a 1: 800 final dilution. Pure 
urushiol and POC. however, were added to proliferation assays in 
the form of urushiol or POC treated cell debris at a 1 : 10 dilution as 
described bdow. along wi,h sOOOR irradiated PBM (2 X 10'/ well) 
as a source of antigen-presenting ceUs. No exogenous IL2 was added 
to any group aside from the IL2 positive control. 
Treatment ofPBM with U rushiol or PDe Both urushiol and 
PDC were added to proliferation assays in the form of treated PBM. 
Ten million irradiated (5000 R) PBM were resuspended in 0.2 m! of 
either DMSO alone or a OMSO solution of pure urushiol or POC at 
O.OS mg/ ml. The cells were incubated at 37'C for 30 min and 
washed three times (centrifugation 2,000 RPM X 10 min). The 
nonviable cell debris was then resuspended in 1.0 m! of supple-
mented RPMI 1640 medium for addition to proliferation assays at a 
I : 10 final dilu,ion along wi,h viable irradiaced (sOOOR) antigen-
presenting cells. 
Cytotoxicity Assay Cultured T cells were tested for cytotoxicity 
against the NK rarget K562 as well as concanavalin A (ConA: Cal-
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biochem, San Diego, CA) treated Oaudi cells to test for cytotoxicity 
by lectin approxima,ion (LDCC). Target cells (5 X 10') were la-
beled with SICr by incubation for 1 hat 37·C in 0.2 ml of sodium 
chromate in saline (ImCu/ml, New England Nuclear, Dupont. 
Wilmington, DE). Targets were then washed and resuspended at 
I X 10'/ ml insupplemenced 10% human ABserum RPM11640. A 
standard 4 h cytotoxicity assay was performed as previously de-
scribed using V-bottomed wells [151. Effectors were added at 20. 10. 
and 5 effector to target cell ratios. Standard deviations were consist-
ently below 10% of the [otal cpm and spontaneous release varied 
between 15%-25% of total release. For lectin dependent cellular 
cy,o,oxicity (LDCC). ConA was added '0 cadiolabded Daudi cells 
at a final concentration of 25 pg/ m1. UncOl~ugated Daudi cells 
were included as a negative control. Total release was determined by 
addition of 1 % NP40 detergent in distilled water. Percent cytotox-
icity was calculated by the formula 
% 
. . cpm - spontaneous release 00 
cytOtOXIClty = X 1 . 
total release - spontaneous release 
Antigen. induced Lympbokine Production Production ofIL2 
and gamma interferon were measured following stimulation with 
rhus extract. Cultured clone cells were washed extensively and in-
cubated in 10% human AB serum RPMI 1640 supplemented with 
4 mM glutamine and gentamycin with a (1 : 800) dilution of rhus 
extract. Cells were cultured in flat bottom 96-well microtiter trays 
(Costar. Cambridge. MA) wi,h a final volume of 0.2 ml per well. 4 
wells per group. at I X 10' cultured T cells per wdl. Autologous 
(E-) cells irradiated sOOOR wece added at I X 10' cells per well as a 
source of antigen-presenting cells. Culture supernatant was har-
vested daily for 3 d from sets of four wells and pooled for each 
group. IL2 content was measured on each day, but gamma inter-
feron content was only measured in day 3 culture supernatant. 
IL2 content was assayed using 'H-thymidine uptake by an IL2 
dependen, cell line (CTLL-2). Recombinan, IL2 (Biogen. Cam-
bridge, MA) standards were used to construct a standard curve. 
Gamma interferon concentration was assayed using a solid-phase 
radioimmunoassay (Centocor, Malvern, PA) with recombinant 
gamma interferon standards. 
P okeweed MitogeD Induced IgG P roduction PBM (I X 10' 
cdls/mI) were incubated in RPM! 1640 medium containing 20% 
fecal calf serum (FCS. HyClone Labs. Logan. UT). 1% penicillin-
streptomycin, 25 mM HEPES (Microbiological Associates, Wal-
kersville, MO). 0.5% sodium bicarbonate, 4 mM glutamine, and 
pokeweed mi,ogen (PWM) a' a final dilu,ion of I: 200 (Gibeo. 
Grand Island, NY). Cloned T cells were added in variable numbers 
to 1.0 ml ofPBM, which were then aliquoted to U-bottom micro-
,icer wells (96 well teays. Nunc/ lntermed. Thousand Oaks. CAl. 
0.2 ml/well. 4 wells per group. PBM were autologous wi,h ,he 
T-cell clones. Cultures contained either DMSO (1 : 800) or antigen 
(rhus extract I: SOO final dilution). After 7 d of incubation in 7.5% 
CO2 at 37°C, 0.150 ml of culture supernatanr was harvested from 
each well and pooled. IgG content was then determined by compet-
itive solid-phase radioimmunoassay using 'lSI_human IgG as pre-
viously reported [16J. All satnples were assayed in ttiplicate and IgG 
was determined by reference to a standard curve generated concur-
rently. 
RESULTS 
Limiting D ilution Analysis of the Frequency of Rhus Spe-
cific Peripheral Blood T .cells Experiments were performed to 
determine both the optima1 concentration of recombinant IL2 (rlL) 
and day of rlL2 addition for limi'ing dilu,ion analysis (LDA). Ob-
viously, the LOA is dependent upon selective proliferation of those 
T cells specific for rhus. For this reason, it was thought that high 
levels of IL2 would be undesirable, as this would stimulate cells 
nonspecifically by 'he low affinity IL2 recep,or [17]. resul,ing in 
high background proliferation. Delaying the addition of IL2 for 
several days should also increase selectivity, as several days arc re-
quired to generate IL2 receptors following antigen stimulation ofT 
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Table I. Limiting Dilution Analysis of the Frequency of Rhus Specific Peripheral Blood T Cells· 
Frequency of Responding Cells 
rll2 Addition No Antigen Rhus Extract Difference 
A. 5 U/ ml Day I 1/ 1031 1/ 825 1/ 4129 
(1 / 827 - 1/ 1286)' (1/ 659 - 1/ 1039) 
B. 5 U/ ml Day 6 1/ 27368 1/ 2651 1/ 2935 
(1 / 14255- 1/ 52542) (1/ 2065-1 / 3404) 
C. 20 U/ ml Day 6 1/ 1866 1/ 1091 1/ 2627 
(1 / 1481 - 1/ 2351) (1/ 875 - 1/ 1361) 
• Optimal concentmion and rime of addition of recombinant IL2 (rIU) was detennined for the qwntitation by limiting dilution analysis of the frequency of rhus specific 
penphcnl blood T cells. T cells were added to wells at 3 X 10l, 1 X t(P,and 3 X HP cdls pe:rwell (60 wells per dose) along with 5 X lOt (4000R) autologous PBM . OupliOite sets of 
plates were ellher cultured with media alone or rhus extr.llct ( I : 800) contai ning media. Positive wells wen~ scored on day 21 and frequency determined as described . 
.. 95% Confidence interval. 
ce lls PSI . Recombinant IL2 (Boehringer Mannheim) was added to 
LOA on days 1 and6ar5 U/ml (days 1 and 6) and 20 U/m! (day 6). 
The frequency of responding cells was determined both in the ab-
sence of exogenous antigen and in the presence of rhus extract. As 
shown in Table 1 and Fig I , addition of rlL2 (5 U/ ml) on day 1 or20 
U/ ml rlL2 on day 6 resulted in unacceptable backgrounds with 
ovcrlapping error bars and 95% confidence intervals. The addition 
of 5 U/ml rlL2 on day 6 resulted in negligible background 
(frequency = 1/ 27,368) with non-overlapping error bars. How-
ever, the estimated frequency of rhus specific T cells (1 / 2935) was 
greater than that obtained with IL2 addition on day t, once the 
background frequency was subtracted from the frequency estimate 
for rhus specific cells. Addition of 20 U of rlL2 on day 6 gave the 
same result with higher background. In two repeats of the above 
experiment, using the same donor and addition of 5 U/m1 rIL2 on 
day 6, the frequency of rhus specific T cells was 1/3300 and 
1/ 4000. Thus, the use of 5 U/ ml rlL2 on day 6 appears to result in 
both greatcr sensitivity and specificity . 
Validation of the above tech nique requires that the antigen speci-
ficity of the responding wells be determined. For this purpose, cells 
from wells showing growth were washed and resuspended with A) 
media alone, B) irradiated (4000R) PBM, or C) irradiated PBM + 
rhus extract (1 : 800). 3H-thymidine was added at 24 hours and cells 
were harvested 18 hours latcr. As shown in Table II, those wells in 
group B (Table I) which showed growth in the absence of antigen, 
demonstrated proliferation in response to autologous PBM. Thus. 
under the optimal conditions devdoped above, positive wells in the 
absence of antigen represent a form of autoreactivity. This autoreac-
tivity, which can be quantitated as the frequency of autoreactive T 
cells, may be of biologic importance and deserves further investiga-
tion. As expected. wells that were positive in the presence of rhus 
showed proliferation in response to rhus. 
Generation of Urushiol Speci6c T-Cell Clones T-cell clones 
were developed from the PBM of a urushiol sensitive donor by in 
vitro sensitization, followed by cloning at one cell per well and 
expansion in IL2 containing medium as described. A total of nine 
rhus specific clones were derived in three independent in vitro sen-
sitizations from the same donor. None of these lines was 
CD4+CDS-, and attempts to develop a urushiol specific 
CD4+CDS- line by anti-CDS+ complement treatment of uru-
shiol specific bulk cultured PBM were unsuccessful on two at-
tempts. Five clones were chosen for extensive analysis based on their 
urushiol specificity (described below) and their growth characteris-
tics. The phenotypes of these clones are shown in Table III. All five 
clones are CD8+. All clones had minimal levels of NKH1 expres-
sion, an NK cell marker. However, RLBIO coexpressed CD4 and 
CDS. 
Antigen-Speci6c Proliferation ofT-Cell Lines To assess the 
antigen specificity of these T-cell lines they were cultured either 
without stimulus, with IL2 alone, or with irradiated autologous 
antigen-presenting cells (PBM) in the absence or presence of various 
antigens. The five clones chosen for analysis all exhibited prolifera-
tion in response to both rhus extract and pure urushiol (Table IV). 
No exogenous IL2 was added to the groups containing antigen. 
Thus, proliferation also implies the ability to synthesize IL2. 
That the rhus extract and urushiol act as antigens and not mito-
gens is supported by the fact that many clones were derived in the 
above sensitizations which were unresponsive to these antigens. 
Most of these non-antigen specific clones were either CD4+ and 
autoreactive or CD8+ with NK activity (data not shown). Auto-
reactivity was determined by proliferation to irradiated PBM in the 
absence of antigen, which was negative for the urushiol specific 
clones. Rhus extract generally gave better proliferation than pure 
urushiol, which may reflect problems with conjugation of the uru-
shiol. Although the donor was sensitive to tetanus toxoid and teta-
nus toxoid specific clones have been generated from this donor, 
tetanus toxoid did not induce proliferation of these urushiol specific 
dones. As previously reported by Vera Byers (9), PDC was found to 
be inferior to urushiol as an antigen. Only one clone, RLB 1 0, gave 
reproducible and significant proliferation in response to PDC (this 
was repeated three times). 
Lymphokine Production hy Cultured T cells Levels of IL2 
and gamma interferon (IFN) production following stimulation of 
cultured T cells by rhus were assayed by culture in supplemented 
10% human serum RPM I 1640 with rhus extract (1 :800) and 
5000R irradiated autologous (E-) antigen-presenting cells as de-
Table II. Antigen Specificity of Positive Limiting Dilution Analysis Wellsa 
Positive wells 
Condition No antigen (N - 9)b Rhus present (N - 69)( 
A. Media 
B. PBM (4000R) 
C. PBM (4000R) + rhus 
1030 (51)' 
5284 (44) 
5959 (41) 
203 (10) 
382 (18) 
1132 (35) 
• The antigen specificity of positive wells in the limiting dilution analysis (LOA) shown in Table I was determined by prolifer.lltion andlH-thymidineuptake. Wells from Table I , 
group 8 (5 U rlL2 added day 6) were tCited for prolifer.llfion either to A} media alone. B} PBM (4000R), or C) P8M (4000R) + rhus extraet. 
~ Initial wells cont2ined irr.lldiated PBM with nO exogenous ~ntigen (Table IB; no antigen). 
• Initial wells contained irradiated PllM + rhu5 C'xt:ract (Table IB; rhw: eXtT2ct). 
~ cpm (SEM). 
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Table III. Phenotype ofT-Cell Clones' 
Neg T3 T4 T8 NKHI 
RL2-IO I' 97 I 87 11 
RLA-2 2 96 I 92 7 
RLBIO 2 99 98 73 4 
ItA-I I 98 6 90 3 
RLA3 6 96 II 91 
• T cdls were st<ilined by indlfC~ct irnmulloAuorr-sccllcc :md :l.nalyud on an Epics C 
cytoflllorograph (Coulter Electronics. Hialeah, FL). 
It Pereem of cdls positive: 10,000 cells .:malyted. 
scribed. Culture supernatant was harvested on days 1,2, and 3 and 
assayed for fL2 and gamma interferon. Culture supernatant from 
conrrol cultures of irradiated antjgen-presenting cells + rhus con-
tained undetectable (less than 0.3 U/ ml) levels of activity of either 
Iymphokine. 
IL2 production was generally low level (Table V) with a maxi-
mum value of 6.8 U/ml. Likewise, gamma inrerferon production 
was also low level with the exception of RLA2 (120 V/ ml). In 
contrast, reports in the literature for Iymphokine producing elones. 
generally exceed 100 V/ml for gamma interferon [5]. 
Cytotoxicity of T ~cell C lones The T-cell clones were next 
characterized as to their cytotoxic potential against both the NK 
target, K562, and lectin treated targers (LOCC). Cytotoxicity was 
measured using a 4-h StCr release assay as described. None of the 
five clones tested had significant NK activity as measured by killing 
ofKS62 (Table VI), although several IL2 generated NK lines tested 
concurrently produced in excess of 70% cytotoxicity at a (20: 1) 
effector target ratio (data not shown). In contrast, three of the 6ve 
clones had high levels ofLOCC against lectin approximated targets 
(RLA-2, 70%; RA-I, 62%; 1tA-3, 780/0). A CD4+ tetanus toxoid 
speci6c helper clone tested concurrently showed only 13% LDCC, 
which was similar to the levels shown by RL2-10 (23%) and RLBIO 
(t 7%). Thus it appears rhat three of these lincs have a high Icvel of 
cytotoxic pmentia!. However, it has nor been possible to detecr 
cytotoxicity against rhus conjugated autologous targets (dara not 
shown), and the significance of rhis cytotoxicity is uncertain. 
Immunorcgulatory Effects of Rhus Specific Clones on IgG 
Production Rhus speci6c T-cell clones were added to a pokeweed 
mitogen (PWM) stimulated IgG synthesis system using autologous 
PBM. After 7 d of culture. culture supernatant was harvested and 
IgG production was dctermined by RIA. T cells were added at both 
I X 10'/mland 1 X 10'/mltoPBM(I X 10'/ml) to yield ratios of 
1 : 100 and I : 1000, respectively. Cultures were initiatcd both in the 
presence of DMSO (1: 800) and rhus extract (I : 800). Reference 
cultures contained cit her DMSO or rhus extract, but did not contain 
T-cell clones. 
As shown in Table VII. three clones (RA4, RA7. RLA3) sup-
pressed PWM triggered IgG production in the presence of rhus 
antigen but not in its absence. Thus, these clones appear to be anti-
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Table V. Lymphokinc Production by Cultured T Cel lsJ 
IL2 Gamma-IFN 
RL2-10 5.0(0.4)' 19' 
RLA-2 3.5(0.2) 120 
RLBIO 6.8(0.2) 12 
ItA-I 5.4(0.3) 13 
1tA·4 4.7(0.2) 10 
1tA-7 0.6(0.1) 1.0 
• T -cdl clones were cultmed In 10% human serum RPMI 1640 al I X IIY'/ml wilh 
(I : 800) rhu~ ext net and 2 X lOs/1Il1 SOOOR irradiated autologous (E-) eells in fl at 
bonoll1 96-wdl tnys (0.2 ml/well; 4 wells/dercnmnauon). Culture superrutlnt wu 
h:l.f'·estC'd daily. IL2 content is shown for 24 hand gamma-IFN conlem is shown for 
72 h. 
" IL2 umts/ml (S EM). 
< Gamml- IPN unlts/m!' 
gen triggered, nonspecific suppressor cells. However, clones RA 1 
and RL2-1 0 did not suppress and produced an augmentation of IgG 
production. The suppression produced by clones RA4. RA7, and 
RLA3 is unlikely to be the result of artifact such as media depletion 
or crowding, because the effect was seen at ratios of 1 : tOO and 
t : 1000. Suppression did not correlate with gamma-IFN produc-
tion either (Table VI). In addition, other rhus speci6c clones did nor 
induce suppression. The ability of SOOOR irradiated RLA3 to sup-
press IgG production also argues against media depletion or crowd-
ing as a mechanism of suppression. 
DISCUSSION 
Five untshiol specific T-cell clones derived from the peripheral 
blood of a rhus sensitive donor are described in this report. All five 
clones were CD3+CD8+, although RLB 10coexpressed C04. The 
clones proliferated in response to both extract of leaves and pure 
urushiol. However, only RLBIO gave significanc proliferation (0 
POC, which was previously described as an inferior antigen [91. IL2 
production by these lines varied from 0.6 to 6.8 units/ml in re-
sponse to antigen, and gamma interferon production varied from 
1.0 to 120 units/ ml. Previously reported values for Iymphokine 
production by CD4+ lines specific for nickel sulfate range from 9 to 
32 units/ lnl for IL2 and 500 to 28,000 units/ ml for gamma inter-
feron. The cells had neg ligible levels of NK activity. However. 
three of five clones showed considerable cytotoxicity againsr lectin 
approximated targets. As cytotoxicity was not detected against rhus 
treated autologous targets (data not shown), the signi6cance oflec-
tin mediated cy totoxicity is uncertain. 
Three clones were found to suppress pokeweed mitOgen (PW M) 
induced IgG production in the presence of rhus. These antigen-
triggered nonspcci6c suppressor cells may have a role in the down 
regulation of delayed hypersensitivity reactions to hapten. 
Urushiol in this system acted as an antigen and nOt as a mitogen. 
This is supported. first, by the finding that many clones did not 
respond to urushiol and, second, by the inability of PBM from 
nonsensitive donors to respond (0 urushiol (data not shown). This 
Table IV. Antigen-Specific Proliferation ofT-Ceil Cloncs~ 
RL2·1O RLA3 RLBlO RLA2 RAI 
Media 5.5(0.3)' 0.2(0.1) 0.3(0.1) 0.7(0.1) 3.4(0.2) 
IL2 43.2(1.0) 14.0( 1.5) 12.7(0.4) 10.7(0.4) 13.7(1.2) 
PBM 3.5(0.3) 0.5(0.2) 0.5(0.2) 1.1(0.3) 3.5(0.1) 
Rhus extract 57.8(5.9) 8.3(2.1) 41.5(1.8) 9.3(0.4) 10.2(0.7) 
Urushiol 16.9(1.2) 6.8(2.0) 24.9(1.6) 4.2~0.2) 8.5(1.1) 
POco 2.0(1.0) 0.2(0.1) 10.4(1.5) 3.10.2) 2.4(0.4) 
OMSO 3.5(0.3) 0.4(0.2) 0.4(0.1) 0.6(0.1) 3.4(0.2) 
Tetanus toxoid 7.6(0.8) NO NO 0.9(0.2) NO 
• T-cell clones weft' extensivdy washed and cultured (1 X lOs cells/well) with either medi:.l alone. IL2. 5000R ir~diatcd PBM (2 X 1000/wcll). or irradiated PBM + antigen as 
shown. l H-thYlIlldlllc wu addcd at 24 h and cells were' harvested at 36 h. Urushiol, POC, and DMSO were added in the fOfm of treated 1'8M as described. 
It cpm X 10-) (SEM). 
~ Pcnt~dccy[ catechol. 
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Tab le VI. CytotOxicity of T-Cell Clones' 
K562 targets ConA targets 
20' 10 5 20 10 5 
RL2·10 2%' 2% 1% 23% 18% 13% 
I\LA.2 1% 1% 0% 70% 68% 53% 
I\LBIO 1% 0% 0% 17% 15% 10% 
RA·I 0% 0% 0% 62% 54% 40% 
RLA·3 9% 78% 
RT4d 0% 0% 1% 13% 10% 9% 
• CytOtOXIcIty wu dett'rmlned in a 4-h uCr tdease :lss.~y ~g~U1S1 KS62 (N K urget). 
D~udi ~nd D~udl :lpproxim~ted with ConA (lectin dependent cdlulu cytotoxicity). 
CytolOxicity against Daudl wlthom ConA was 3% or 1"5. 
~ Effector: Urget ratio. 
~ l-'C'rce-nt CYlotoxicity: SEM 1"5 Ihan 7% or total cpm. 
4 ItT4 is a CD4+ hdpc-r done J~cific fOf leunu.s foxoid included a~ a negative 
control. 
later point has been well established by Vera Byers et al [9J. The 
non-mitogenicity of urushiol was important to establish because it 
has been reported that urushiol may activate protein kinase C [19]. 
MediatOrs of delayed hypersensitivity responses include IL2 and 
gamma interferon. In addition to its role as a T-cell growth factor 
120] IL2 may induce nonspecific NK activity r21]. G:ullIlla inter-
feron is known to induce DR expression on endothelium 1221 and 
keratinocytes /23/, as well as alter lymphocyte homing properties of 
endothelium 24. Ie is also reponed to inhibit suppressor cells that 
regulate delayed hypersensitivity [25] and to activate macrophages 
1261. All of the above may be significant in the generation of a 
delayed hypersensi rivity response. In addition, the induction of DR 
on endothelial cells and keratinocytes is hypothesized ro amplify an 
immune response by recnliting 3utoreacrivc lymphocytes. Such re-
cruirment of autoreactive lymphocyres could possibly explain the 
"angry back syndrome" and rhe "aucoeczematizatioll" response ob-
served by clinicians. 
Animal studies have determined thar both cytotoxic CDS {Lyt2} 
cells [4J and helper CD4 (L3T4) ce lls [3J arc cap.ble of mediating 
delayed hypersensitivity. However, artempts to clone anrigen-spe-
cific T cells from the peripheral blood of parients sensitive to either 
nickel sulfate [5J or cobalt chloride [6J h.ve recovered only CD4+ 
clones. Many of these CD4+ clones produce gamma interferon in 
excess of 100 llnits/ml and arc good candidates for mediators of the 
delayed hypersensitivity response. In contrast, only one of the five 
CDS+ clones reported here produced gamma inrerferon in excess of 
100 units/ml. The role of remaining cell clones requires further 
investigation. 
Table VII. Immunoregulatory Effects of Rhus Specific Clones 
on IgG Production~ 
lone DMSQb Rhus~ 
Exp.l Rererenced 8.2r 3.4 
RAI I X 10'/mi 9.0 5.0 
1 X 103/ml 6.5 4.6 
RA4 I X 10'/ mi 5.8 0.9 
t X 1O)/ml 5.8 2.9 
RA7 I X 104 /1111 8.5 0.75 
I X 1O'/ml 10.0 0.85 
RLA3 1 X 104/ 1111 5.8 0.2 
10001\ 0.3 
5000R 0.3 
Exp.2 Rererence 4.8 3.2 
RL2·10 1 X 104 8.0 4.8 
I X 10' 5.7 5.0 
• ClonC'd T cdls were added 10 (1 X I~/ml) PBM + PWM ~nd aliquole'd 0.2 mlf 
well as described. Culture' 5upC'ml!ln! was h'lITvC'Ste'd on day 7 and as~yed ror IgG by 
RIA . 
~ DMSO (I ; 800) adde'd as control ror rhm Ulne!. 
• Rhul utnct (I : 800). 
~ lSG production in the- lbSC'lIce orT-cdl clolle-. 
• IgG (nucrogranu/ ml) SEM w.u lC'Ss (hln 10%. 
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The preponderance of CD8+ clones requires COmment. No 
CD4+ urushiol specific clones could be derived from this donor in 
several attempts, despite lysis of CDS+ cells either prior to or fol-
lowing in vitro sensitization. This is not an artifact introduced by 
the cloning technique because CD4+ retanus toxoid specific clones 
were easily derived from the same donor using the same procedures 
(data not shown). In addition. the proliferative response of this 
donor's PBM to rhus extract was predominantly mediated by 
CD8+ cells (data not shown). It should be noted thar this dOllor was 
several months post rhus dermatitis, a time at which Yen Byers et al 
were unable to detect in vitro reactiviry to urushiol using slightly 
different methods of antigen presen tation {9]. No general statement 
on rhus antigeneity for CD8+ cells can be made on the basis of a 
single donor. However, there is much evidence that CD4+ class II 
MHC restricted cells arc required for rhe recognirion of hapren 
[27,2S1 and immunohistologic studies have found a high proportion 
of CD4+ cells in the infiltration of del.yed hypersensitivity [291. 
Given the above, it would be expected that CD4+ urushiol specific 
cells would be detected during an acute immune response, either in 
the peripheral blood or in the skin lesio~. I~ is al.so ~ssible that 
residual CD4+ memory cells tend to rema1l1 either 111 skin or lymph 
nodes and thus escape detection. 
The antigen-triggered suppressor cells described in this system 
arc similar [0 chose previously cloned from lesions of lepromatous 
leprosy [30-321. In both systems, nonspecific suppression could be 
triggered in the presence of antigen. It is of interest that these 
suppressor cell s were generated from a dOllor 11 months post-rhus 
dermatitis. suggesting thar they may function in down regulating 
the response to hapten. 
In conclusion , we report the isolation of urushiol specific CD8+ 
T-cell clones from the peripheral blood of a rhus sensitive donor. 
All clones proliferate to both urushiol and leaf extract, suggesting 
rhat urushiol and related catechols are the sole allergens of Toxic(}-
deI/drOll radical/s. A procedure was also described for the quantitation 
of rhus specific cells in peripheral blood. Several clones could sup-
press IgG production in the presence of rhus extract, suggesring 
they might have a down-regulatory role in the response to hapten. 
Pllrt' l4flulliol a"d PDC Ult,/, a .~e,.erOIIS gift of Dr. Harold Batr (FDA, Bethtsda, 
MI)) . Wi' Ivish 10 Iha/lk Ms. Caml Almol.d fi1r preparirlg tht maIlUS(ril" a"d Dr. D. 
Srilll Sch mid (CDC, At/mua, GA) Jor pnwiding tilt (Ompule'r program Jor s/alis/i-
(al'Hla/ysis of "'miting dilulion QJsa)'s. 
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NIH WORKSHOP REPORT ON THE NON-
DERMATOLOGICAL COMPLICATIONS O F 
EPIDERMOLYSIS BULLOSA 
In September. 1986, the National Institute of Arthritis and Musculoskeletal and Skin 
Diseases (NIAMS), National Institutes of Health. funded a workshop on the Non-Dermato-
logical Complications of Epidermolysis Bullasa (EB). After hearing presentations by a panel 
of scientific experts on such subjects as basic skin biology. wound healing, esophageal stric-
tures !lnd webbing, complic:uions related to malnutrition, gascrointestinal m:mifestatioru, eye 
lesions, dental involvement and orthopedic deformities, a comf.rehensive report was prepared 
and published. Free single copies of this report are availab e from: Arlene Pessar, R.N., 
D.E.B.R.A. of America, Inc., 451 Clarkson Ave., Room E6101, Brooklyn, New York 11203 
(Tel. 718/774-8700). 
